PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
about
Ecophysiology of omega Fatty acids: a lid for every jarVitamin E and nonalcoholic fatty liver diseaseNrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitisOmeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain modelInsulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy InhibitionLipotoxicity in the liver.Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in miceAnti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet.Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.Cardiac function and disease: emerging role of small ubiquitin-related modifier.Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissueDanqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway.Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosisModerate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis.The direction of cross affects [corrected] obesity after puberty in male but not female offspringBlack rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation.Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in miceDietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice.Molecular Interactions between NAFLD and Xenobiotic Metabolism.Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease.Eicosanoids in metabolic syndrome.Korean pine nut oil replacement decreases intestinal lipid uptake while improves hepatic lipid metabolism in miceEffects of d-α-tocopherol supplements on lipid metabolism in a high-fat diet-fed animal model.Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte InjuryProteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.Co-expression network analysis identifies transcriptional modules in the mouse liver.Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis.Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity.Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.Cytochrome P450 4F2 polymorphism in patients with liver cirrhosis.Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.Kidney Androgen-Regulated Protein (KAP) Transgenic Mice Are Protected Against High-Fat Diet Induced Metabolic Syndrome.Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.Cytochrome P450-2E1 is involved in aging-related kidney damage in mice through increased nitroxidative stress.Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase sign
P2860
Q26859035-21DE59D6-635C-4FD6-AE29-854B15B6E1F2Q27693883-B61D6A33-CF9D-4783-8941-B051228A69D8Q28392304-3CF82C78-87FF-4E5E-B4F3-4E15A2F39E3EQ28395323-C3CFA73A-5933-45FB-A31C-DD50376B8E73Q28834030-85389D51-EAEA-4BE2-B9B7-8EEBA339A649Q30355131-7F79D2ED-1975-4E58-B63C-808F46DB64ACQ34566467-E3E61A94-4513-4B2D-AD7D-C7AF892CE3BBQ34685423-D5EFF4C2-2459-4EC9-821B-F599F02C9204Q35022972-D23E63C5-08D1-4E97-B255-BD72B750BF47Q35032636-ACDB82FD-3748-4DEE-A382-9BC246DAE2A8Q35041508-EE804986-ECE9-4E22-B27F-86AE1CFF6E11Q35163413-965E54E8-E59A-4030-8F03-F339583E4083Q35550990-F8ADB82B-FB99-44D8-B6B4-CA274B3DDCB1Q35721070-A009B3BA-CC48-4BC8-88ED-466FD2843203Q35834853-C8C76A2A-1F72-4CBB-837E-741516B863D5Q36007128-8763C85B-E7D4-4A5A-B6A7-0A1BCE680BB5Q36098104-DF855495-D4D1-4147-B478-85C3BB1E1EE2Q36383651-2048C1E9-1D02-4DD7-A992-EF2025268BD5Q36549795-F5149609-53DD-434D-A2DB-47B092DA7F6DQ36831136-78FDAA3E-1EFC-4E44-B064-DB0EC3DFA8C3Q36911098-CA4A0CA1-419A-411A-BCCE-16D80EA25E00Q37284436-A8496AF3-472E-4057-94E2-E28B6A987EC0Q37397434-E34D8371-4055-499E-8B5A-0191E0C49BD6Q37662933-286F3719-E03C-4465-9E7E-65AD2AA8C1B6Q37670520-2EE423D4-A9C1-4111-A340-2BE4A48ADCF5Q37691021-95FFCC13-CC4E-4466-8135-61E14D1E9645Q38476964-7FC6FEBC-EE62-4485-ADBB-491AC994A387Q38776013-20FE35A6-763C-4315-968F-89001AD37857Q38903724-ADE96F5B-B6F0-4F78-AACF-45A84953E068Q39440693-596D7C0D-5715-4A5D-B25D-676A7B5E4364Q39609137-048014E7-22CB-4F3C-909F-76154DAABC06Q39847763-18D3912D-187C-489A-B658-761E95406453Q41457655-7D7221AA-F9D8-4BA1-A7E1-92D5A956D200Q42250253-9918137C-01CC-436C-8EAE-68C214FA907EQ42872871-E16AF0A2-78BC-415A-92EC-6D82FE3A9753Q47113471-A93F7C90-B211-4670-A0E5-B3C68E88268FQ47546227-A032F639-1B95-4E21-BFAD-6C57527747E7Q47658696-75F401F1-35EC-4A93-B083-C692D5C26C22Q51312147-BE5C6523-B287-4FE5-B122-501DEA1DE1EEQ51593895-0EC92B21-5FCC-486B-9B31-AFF84A0B6108
P2860
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@ast
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@en
type
label
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@ast
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@en
prefLabel
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@ast
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@en
P2093
P2860
P356
P1433
P1476
PPAR/RXR Regulation of Fatty A ...... oxicity in Fatty Liver Disease
@en
P2093
Byoung-Joon Song
Homer Wiland
James P Hardwick
Mohamed A Abdelmegeed
P2860
P304
P356
10.1155/2009/952734
P577
2009-01-01T00:00:00Z